REGENXBIO Inc. (RGNX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Core Insights - REGENX is actively engaged in various initiatives within the gene therapy sector, focusing on multiple clinical areas [2] Company Overview - REGENX is introduced as a gene therapy platform, indicating its involvement in innovative treatments [2]